日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial

NCT02326974 临床试验中 HER2 阳性乳腺癌的 HER2 异质性和治疗反应相关性特征

Zheqi Li, Otto Metzger Filho, Giuseppe Viale, Patrizia dell'Orto, Leila Russo, Marie-Anne Goyette, Avni Kamat, Denise A Yardley, Vandana Gupta Abramson, Carlos L Arteaga, Laura M Spring, Kami Chiotti, Carol Halsey, Adrienne G Waks, Tari A King, Susan C Lester, Jennifer R Bellon, Eric P Winer, Paul T

A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer

TROP2/Claudin 程序介导免疫排斥以阻止乳腺癌检查点阻断

Bogang Wu, Win Thant, Elena Bitman, Ting Liu, Jie Liu, Eleftherios I Paschalis, Katherine H Xu, Linda T Nieman, David T Ting, Nayana Thimmiah, Sheng Sun, Rachel O Abelman, Steven J Isakoff, Laura M Spring, Aditya Bardia, Leif W Ellisen

A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression

在先前的细胞周期依赖性激酶 4/6 抑制剂进展后,与 Abemaciclib 在 ESR1 突变乳腺癌中的应用相关的基因面板

Jamie O Brett, Taronish D Dubash, Gabriela N Johnson, Andrzej Niemierko, Veronica Mariotti, Leslie S L Kim, Jing Xi, Apurva Pandey, Siobhan Dunne, Azadeh Nasrazadani, Maxwell R Lloyd, Avinash Kambadakone, Laura M Spring, Douglas S Micalizzi, Maristela L Onozato, Dante Che, Utthara Nayar, Adam Brufsk

Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy

连续单细胞基因组学揭示了早期乳腺癌患者在接受内分泌联合 CDK4/6 疗法治疗后,耐药性的趋同亚克隆进化。

Jason I Griffiths #,Jinfeng Chen #,Patrick A Cosgrove,Anne O'Dea,Priyanka Sharma,Cynthia Ma,Meghna Trivedi,Kevin Kalinsky,Kari B Wisinski,Ruth O'Regan,Issam Makhoul,Laura M Spring,Aditya Bardia,Frederick R Adler,Adam L Cohen,Jeffrey T Chang,Qamar J Khan,Andrea H Bild

Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses

在临床乳腺活检过程中进行系统性组织采集是可行、安全的,并且能够进行高内涵转化分析。

Siang-Boon Koh # ,Brian N Dontchos # ,Veerle Bossuyt # ,Christine Edmonds ,Simona Cristea ,Nsan Melkonjan ,Lindsey Mortensen ,Annie Ma ,Kassidy Beyerlin ,Elyssa Denault ,Elizabeth Niehoff ,Taghreed Hirz ,David B Sykes ,Franziska Michor ,Michelle Specht ,Constance Lehman ,Leif W Ellisen ,Laura M Spring

Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models

化疗在乳腺癌模型中引发促转移的细胞外囊泡

Ioanna Keklikoglou #, Chiara Cianciaruso #, Esra Güç, Mario Leonardo Squadrito, Laura M Spring, Simon Tazzyman, Lore Lambein, Amanda Poissonnier, Gino B Ferraro, Caroline Baer, Antonino Cassará, Alan Guichard, M Luisa Iruela-Arispe, Claire E Lewis, Lisa M Coussens, Aditya Bardia, Rakesh K Jain, Jeff

FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer

FGFR1 扩增介导转移性激素受体阳性 (HR+) 乳腺癌的内分泌抵抗但保留了 TORC 敏感性

Joshua Z Drago #, Luigi Formisano #, Dejan Juric, Andrzej Niemierko, Alberto Servetto, Seth A Wander, Laura M Spring, Neelima Vidula, Jerry Younger, Jeffrey Peppercorn, Megan Yuen, Giuliana Malvarosa, Dennis Sgroi, Steven J Isakoff, Beverly Moy, Leif W Ellisen, A John Iafrate, Carlos L Arteaga #, Ad